ReviewPharmaceutics2025

ROS-Responsive Nanoplatforms for Targeted Tumor Immunomodulation: A Paradigm Shift in Precision Cancer Immunotherapy.

Yuan-Yuan Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.